Moore Matthew Richard has filed 19 insider transactions across 2 companies since January 2024.
Most recent transaction: a disposition of 145000 shares of Ventyx Biosciences, Inc. ($VTYX) on March 04, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Moore Matthew Richard | Chief Operating Officer | D | Stock Option (Right to Buy) | 145000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Moore Matthew Richard | Chief Operating Officer | D | Stock Option (Right to Buy) | 320000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.45% |
| Jan. 2, 2025 | Ventyx Biosciences, Inc. | $VTYX | Moore Matthew Richard | Chief Operating Officer | A | Stock Option (Right to Buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Ventyx Biosciences, Inc. | $VTYX | Moore Matthew Richard | Chief Operating Officer | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 0 | 9999.99% | 0.00% |
| May 2, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | S | Common Stock | 4681 | $8.74 | 145,505.0000 | 69,305,487 | 3.12% | 0.01% |
| May 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 4166 | $0.00 | 150,186.0000 | 69,305,487 | 2.85% | 0.01% |
| March 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | S | Common Stock | 3468 | $11.12 | 146,020.0000 | 69,305,487 | 2.32% | 0.01% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 17650 | $0.00 | 125,572.0000 | 69,305,487 | 16.35% | 0.03% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 19750 | $0.00 | 145,322.0000 | 69,305,487 | 15.73% | 0.03% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 4166 | $0.00 | 149,488.0000 | 69,305,487 | 2.87% | 0.01% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.12% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.12% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | D | Stock Option (Right to Buy) | 35300 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.05% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | D | Stock Option (Right to Buy) | 39500 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.06% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.02% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 26666 | $0.00 | 81,256.0000 | 69,305,487 | 48.85% | 0.04% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 26666 | $0.00 | 107,922.0000 | 69,305,487 | 32.82% | 0.04% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Common Stock | 28000 | $0.00 | 54,590.0000 | 69,305,487 | 105.30% | 0.04% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Moore Matthew Richard | SVP and Chief Business Officer | A | Stock Option (Right to Buy) | 126000 | $0.00 | 126,000.0000 | 69,305,487 | 9999.99% | 0.18% |